Cargando...
Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients
The interaction between the bone marrow microenvironment and plasma cells plays an essential role in multiple myeloma progression and drug resistance. The vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) pathway in vascular endothelial cells activates and promotes angiogenesis. Moreov...
Gardado en:
| Publicado en: | J Clin Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7355441/ https://ncbi.nlm.nih.gov/pubmed/32517267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061765 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|